Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
D000614:Aminocaproates / Q000494:pharmacology*; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D008722:Methods; D010958:Plasminogen / Q000037:antagonists & inhibitors*
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001565:Benzoates; D003509:Cyclohexanecarboxylic Acids; D010958:Plasminogen